From the Editor

May 01, 2009
Pharmaceutical Executive
Our 3-D cover jumps off the page. But the real question for us (and for you) is how do we get everything else to connect?
Apr 01, 2009
Pharmaceutical Executive
Unsolicited advice for FDA's next leader: Keep it real, fight popular delusions, and somehow, please, defend the agency.
Mar 01, 2009
Pharmaceutical Executive
The worst thing about working for most corporations is the inevitable downward pull they exert even on the best of us. That's why it's always sad to lose a company that learned to fight back.
Feb 01, 2009
Pharmaceutical Executive
No one who cares about global health can be happy with a system that only "eventually" delivers drugs and vaccines for the planet's neediest people
Jan 01, 2009
Pharmaceutical Executive
It's just the way life works: You're always crossing the bridge before you get to it—or after it's gone
Dec 01, 2008
Pharmaceutical Executive
Maybe what you're feeling isn't impending doom. Maybe it's just growing pains.
Nov 01, 2008
Pharmaceutical Executive
Is FDA's MO in foreign inspections too broken to fix?
Oct 01, 2008
Pharmaceutical Executive
A vision of pharma's next business model is starting to emerge. But how do we get from here to there?
Sep 01, 2008
Pharmaceutical Executive
The United States makes the best medicines in the world. In days to come, that could be a problem.
Aug 01, 2008
Pharmaceutical Executive
FDA preemption is a hot issue for pharma, and it's likely to get hotter. But it's the wrong issue.
native1_300x100
lorem ipsum